Testosterone to Estradiol Ratios in Fertile and Subfertile Men: A Large Cohort Analysis

被引:0
作者
Panken, Evan J. [1 ]
Hayon, Solomon
Greenberg, Daniel R.
Kumar, Sai Kaushik S. R.
Brannigan, Robert E.
Halpern, Joshua A.
机构
[1] Northwestern Mem Hosp, Dept Urol, 675 N St Clair St,20th Floor,Suite 150, Chicago, IL 60611 USA
关键词
MOTILE SPERM COUNT; INFERTILITY; DIAGNOSIS; OUTCOMES;
D O I
10.1016/j.urology.2024.11.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To validate the established normal testosterone to estradiol ratio and characterize the distribution of testosterone to estradiol ratios in a large cohort of fertile and subfertile men. MATERIALS AND METHODS Retrospective review of adult men (>= 18 years of age) presenting for fertility evaluation between 2002 and 2021 who underwent evaluation by a reproductive urologist, had 2 separate semen analyses and had hormonal testing within 6 months of their index semen analysis. Men were dichotomized into fertile and subfertile groups based on total motile sperm count on 2 semen analyses. The subfertile cohort included men with a total motile sperm count < 20 million on both semen analyses. The main outcome measures were serum testosterone, serum estradiol, and serum testosterone to estradiol ratio. RESULTS Among 816 men, 651 (79.8%) were classified as fertile and 165 (20.2%) as subfertile. Median testosterone (ng/dL) to estradiol (pg/mL) ratios were similar between the groups (14.48 vs 15.00, P = .5). The 20th percentile testosterone to estradiol ratio for the fertile group was 9.77. CONCLUSION This is the largest study to date characterizing testosterone to estradiol ratios in men presenting for fertility evaluation. We validated the 10/1 ratio that was previously established as the 20th percentile for fertile men. We found no difference in testosterone to estradiol ratios between fertile and subfertile men defined by total motile sperm count, highlighting the need for further investigation to better define the cohort of men with infertility who could benefit from aromatase inhibitor therapy. UROLOGY 195: 75-79, 2025. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 18 条
[1]   The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities [J].
Barratt, Christopher L. R. ;
Bjorndahl, Lars ;
De Jonge, Christopher J. ;
Lamb, Dolores J. ;
Osorio Martini, Francisco ;
McLachlan, Robert ;
Oates, Robert D. ;
van der Poel, Sheryl ;
St John, Bianca ;
Sigman, Mark ;
Sokol, Rebecca ;
Tournaye, Herman .
HUMAN REPRODUCTION UPDATE, 2017, 23 (06) :660-680
[2]   Total motile sperm count has a superior predictive value over the WHO 2010 cut-off values for the outcomes of intracytoplasmic sperm injection cycles [J].
Borges, E., Jr. ;
Setti, A. S. ;
Braga, D. P. A. F. ;
Figueira, R. C. S. ;
Iaconelli, A., Jr. .
ANDROLOGY, 2016, 4 (05) :880-886
[3]   Estrogen, a female hormone involved in spermatogenesis [J].
Carreau, S. ;
Bouraima-Lelong, H. ;
Delalande, C. .
ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01) :31-36
[4]   Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios [J].
Gregoriou, Odysseas ;
Bakas, Panagiotis ;
Grigoriadis, Charalampos ;
Creatsa, Maria ;
Hassiakos, Dimitrios ;
Creatsas, Georgios .
FERTILITY AND STERILITY, 2012, 98 (01) :48-51
[5]   Total motile sperm count: a better indicator for the severity of male factor infertility than the WHO sperm classification system [J].
Hamilton, J. A. M. ;
Cissen, M. ;
Brandes, M. ;
Smeenk, J. M. J. ;
de Bruin, J. P. ;
Kremer, J. A. M. ;
Nelen, W. L. D. M. ;
Hamilton, C. J. C. M. .
HUMAN REPRODUCTION, 2015, 30 (05) :1110-1121
[6]   The androgen microenvironment of the human testis and hormonal control of spermatogenesis [J].
Jarow, JP ;
Zirkin, BR .
TESTICULAR CELL DYNAMICS AND ENDOCRINE SIGNALING, 2005, 1061 :208-220
[7]   Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement [J].
Legro, Richard S. ;
Wu, Xiaoke ;
Barnhart, Kurt T. ;
Farquhar, Cynthia ;
Fauser, Bart C. J. M. ;
Mol, Ben .
FERTILITY AND STERILITY, 2014, 102 (04) :952-959
[8]   Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole [J].
Naelitz, Bryan D. ;
Jiang, Tommy ;
Munoz-Lopez, Carlos ;
Sigalos, John Tucker ;
Modiri, Neilufar ;
Cannarella, Rosella ;
Mills, Jesse N. ;
Parekh, Neel ;
Nowacki, Amy S. ;
Vij, Sarah C. ;
Eleswarapu, Sriram, V ;
Lundy, Scott D. .
FERTILITY AND STERILITY, 2023, 120 (04) :746-754
[9]   Fertility Considerations in Hypogonadal Men [J].
Papanikolaou, Nikoleta ;
Jayasena, Channa N. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (01) :133-148
[10]   Evidence of a treatable endocrinopathy in infertile men [J].
Pavlovich, CP ;
King, P ;
Goldstein, M ;
Schlegel, PN .
JOURNAL OF UROLOGY, 2001, 165 (03) :837-841